Nabriva Therapeutics Public Limited Company
Company Summary
Nabriva Therapeutics Public Limited Company was set up on Wednesday the 1st of March 2017. Their current partial address is 25 North Wall Quay, and the company status is Normal. The company's current directors have been the director of 1 other Irish company between them. This Irish company shares its Eircode with at least 703 other companies.
| Company Name: | Nabriva Therapeutics Public Limited Company |
| Company Status: | NORMAL |
| Company Address: | 25 North Wall Quay, , Ireland |
| Key Executive: | Mr Iii |
| Company Size: | Log-In To View |
Key Contact Profile
Mr Iii is a Company Director of Nabriva Therapeutics Public Limited Company since 2025 and a listed Director of 1 other companies.
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
Latest Updates
The latest documents filed with the Companies Registration Office for Nabriva Therapeutics Public Limited Company (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| Form B2: Change of Company Registered Office Address | 23/06/2025 | 15/12/2025 | Join Up | |
| Form B2: Change of Company Registered Office Address | 10/05/2025 | 29/05/2025 | Join Up | |
| B10 CHANGE IN DIRECTORS/SECRETARY | 05/03/2025 | 13/03/2025 | Join Up | |
| B10 CHANGE IN DIRECTORS/SECRETARY | 10/03/2024 | 18/06/2024 | Join Up | |
| B10 CHANGE IN DIRECTORS/SECRETARY | 04/10/2023 | 25/10/2023 | Join Up | |
| THIS COMPANY HAS 108 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
Credit Report
View the Latest Credit Report and Credit Limit on Nabriva Therapeutics Public Limited Company.
| Company Status: | Normal |
| Latest Credit Movement: |  |
| Date of Last Movement: | 01/01/2026 |
| Latest Accounts Filed: | 10/10/2022 |
| Report Based on Accounts: | 31/12/2021 |
| Next Set of Accounts Due: | 30/09/2023 |
| Overdue: | Yes |
| Credit Score: | Join-Up to View |
Full Credit Rating
To View the latest Credit Rating or Credit Limit on Nabriva Therapeutics Public Limited Company simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Directors & Owners
Satisfy due diligence requirements on Nabriva Therapeutics Public Limited Company in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Nabriva Therapeutics Public Limited Company and Anti-Money Laundering checks (AML checks) on Nabriva Therapeutics Public Limited Company
Directors details are available to logged in users.
Ownership Structure
| Company Type: | PLC - Public Limited Company |
Compliance
Log-in now to run Due Diligence checks and Compliance checks on Nabriva Therapeutics Public Limited Company or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
Ask Us A Question...?
More people choose Vision-net over any other search service... ask us why?
Clear Your Compliance Backlog Before 2026
15/12/2025
With the year-end fast approaching, now is the ideal time to streamline your customer data and start 2026 with a clean due diligence slate
CRIF has been named in the ESGFinTech100
24/11/2025
We're excited to announce that CRIF has been named in the '''ESGFinTech100''' for the second year running!
Irish Businesses Face Growing Compliance Pressures
10/11/2025
The results of a recent survey CRIFVision-net carried out of over 550 Irish businesses revealed a significant gap in corporate compliance preparedness
Smarter PEP Screening with Vision-net
03/11/2025
In Ireland, the definition of a politically exposed person (PEP) is broadening under the 6th EU Anti-Money Laundering Directive (AMLD6) to include domestic PEPs